Species |
Human |
Protein Construction |
VEGF R1/FLT-1 (Ser27-Asn756) Accession # P17948-1 |
His |
Avi |
N-term |
|
C-term |
|
Purity |
> 95% as determined by Bis-Tris PAGE |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Immobilized VEGF R1/FLT-1, His&Avi, Human (Cat.No.: Z03964) 2 μg/ml (100μl/well) on the plate can bind Biotinylated Human VEGF121, His Tag |
Expression System |
HEK293 |
Theoretical Molecular Weight |
85.1 kDa |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 100-120 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from a 0.22 μm filtered solution in PBS, (pH 7.4). |
Reconstitution |
It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |

VEGF R1/FLT-1, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Immobilized VEGF R1/FLT-1, His & Avi, Human at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human VEGF121, His Tag with the EC50 of 24.4 ng/ml determined by ELISA.
Target Background |
Vascular endothelial growth factor receptor 1(VEGFR1), also known as Flt-1, is a type I transmembrane glycoprotein of receptor tyrosine kinases (RTKs) family. VEGFR1 acts as a cell-surface receptor for VEGFA, VEGFB and PGF. It plays an important role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration and cancer cell invasion. |
Synonyms |
FLT; FLT1; Flt-1; FRT; VEGF R1; VEGFR1 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.